help button home button Am J Pathol R & D Systems
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Niho, S.
Right arrow Articles by Mukai, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Niho, S.
Right arrow Articles by Mukai, K.
(American Journal of Pathology. 1999;154:249-254.)
© 1999 American Society for Investigative Pathology

Regular Articles

Monoclonality of Atypical Adenomatous Hyperplasia of the Lung

Seiji Niho*{dagger} , Tomoyuki Yokose{dagger} , Kenji Suzuki* , Tetsuro Kodama{ddagger} , Yutaka Nishiwaki* and Kiyoshi Mukai{dagger}

From the Division of Thoracic Oncology,* National Cancer Center Hospital East, Pathology Division,{dagger} National Cancer Center Research Institute East, and Division of Medicine,{ddagger} National Cancer Center Hospital, Chiba, Japan


   Abstract
Top
 Abstract
Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Atypical adenomatous hyperplasia (AAH) of the lung has been postulated as a possible precursor lesion of bronchioloalveolar carcinoma (BAC). The clonality of AAHs from seven female patients was analyzed to determine whether AAH is a monoclonal expansion. All AAHs were identified in lungs surgically resected for BAC. The clonality of the BAC and bronchiolar metaplasia in each case was also analyzed. Approximately 500 cells in each lesion were precisely microdissected from methanol-fixed sections. Adjacent normal lung tissue was collected as a normal control. DNA was extracted for clonal analysis based on an X-chromosome-linked polymorphic marker, the human androgen receptor gene (HUMARA). HUMARA was found to be amplified with or without previous digestion by the methylation-sensitive restriction endonuclease HpaII. Five cases were informative. All 10 AAHs and 7 BACs obtained from the informative cases showed monoclonality, whereas the control cells showed polyclonality. Three different AAH lesions in a single case showed both possible patterns of monoclonality. BAC and contiguous AAH showed identical monoclonality in two cases. Two lesions of bronchiolar metaplasia, which was considered reactive, were polyclonal. Our results demonstrated the monoclonal nature of AAH, and this finding suggests that AAH is a precursor of BAC or a preneoplastic condition.


   Introduction
Top
 Abstract
 Introduction
Materials and Methods
 Results
 Discussion
 References
 
Pulmonary adenocarcinoma is now one of the most common types of lung cancer. Unlike squamous cell carcinoma of the lung, in which precursor lesions have been identified,1-3 the preneoplastic lesion of adenocarcinoma remains undefined. Bronchioloalveolar carcinoma (BAC) is a subset of pulmonary adenocarcinoma and contains three histological types: mucinous, nonmucinous, and sclerosing.4 Recently, atypical adenomatous hyperplasia (AAH) has been postulated as a possible precursor of BAC, and many studies have been conducted to characterize AAH.5-14 Cytofluorometric analyses have showed that the DNA histogram patterns of AAH are intermediate between those of reactive hyperplasia of type II pneumocytes and small-sized well differentiated adenocarcinomas and that AAH is a clonal cellular proliferation closely related to well differentiated adenocarcinoma.15 An image cytometric analysis also showed that some cases of AAH displayed aneuploid histogram patterns.16 Several genetic analyses of AAH revealed that 15% to 39% of AAHs had K-ras mutations.17,18 Immunohistochemical analyses of p53 and c-erbB-2 have indicated that AAH exhibits certain genetic changes associated with malignancy.7,19 However, AAH for telomerase activity has been found to be negative by radioactive in situ hybridization.20 Although evidence has been accumulated that AAH is a precursor of BAC, its preneoplastic or neoplastic character has not been definitely proven.

Monoclonality has been thought to be a fundamental characteristic of neoplasia.21,22 One X chromosome is randomly and permanently inactivated at an early stage of embryogenesis in the female. This leads to somatic mosaicism of normal females with respect to X-linked alleles, with approximately one-half of the somatic cells expressing the maternal allele and the other half expressing the paternal allele. Tumors arising from a single cell will therefore express one of the two phenotypes. Recently, a highly polymorphic trinucleotide CAG repeat in the X-linked human androgen receptor gene (HUMARA) has been used to distinguish between the two X chromosomes23 and detect monoclonality in various neoplastic diseases,24-29 including BAC.30

Bronchiolar metaplasia (or alveolar bronchiolization) may be observed after a variety of insults, such as respiratory infection, exposure to chemical irritants, carcinogens, and circulatory disturbances involving the lung.31 Bronchiolar metaplasia simulates BAC morphologically because the metaplastic epithelial cells proliferate along the alveolar wall32 ; however, it has been considered reactive, not neoplastic, because the epithelial cells do not show atypia.

The aim of this study was to determine 1) whether AAH is a monoclonal expansion, 2) whether the clonality of AAH is consistent with that of BAC when AAH is contiguous to BAC, and 3) whether other peripheral pulmonary lesions such as bronchiolar metaplasia are monoclonal or polyclonal expansions.


   Materials and Methods
Top
 Abstract
 Introduction
 Materials and Methods
Results
 Discussion
 References
 
Patients

Sixty-nine patients underwent resection of the lung because of cancer at the National Cancer Center Hospital East from September 1997 to January 1998. Among them, 21 patients (30%) had concomitant AAH. Eight were male and thirteen were female. Seven female cases in which we found AAHs or bronchiolar metaplasia were available for the analysis of the clonality. All AAHs were identified in lungs surgically resected for BAC. The locations in which samples were taken were assigned by gross dissection.

Histological Criteria for AAH, Bronchiolar Metaplasia, and BAC

The histological diagnosis of AAH was made based on the following criteria, as previously described6,8,9,16,33 : 1) the lesion is localized with well defined boundaries; 2) atypical cuboidal to low columnar or peg-shaped cells, resembling either type II pneumocytes or Clara cells, have proliferated along the slightly thickened alveolar wall, and mild inflammatory infiltration may be present without scar formation; and 3) atypical cells in AAH have variable degrees of nuclear atypia, but it is less prominent than in adenocarcinoma (Figure 1) . Bronchiolar metaplasia is characterized by the presence of ciliated columnar cells extending from the bronchus to the alveoli without atypia (Figure 2) . BAC is defined as pulmonary adenocarcinomas in which most of the tumor grows as a single cell layer along alveolar walls, forming apparent glands of uniform size.4



View larger version (153K):
[in this window]
[in a new window]
  		Figure 1. Representative histopathological findings of atypical adenomatous hyperplasia (AAH) of the lung in case 2 (AAH 2-2). The lesion is localized and has well defined boundaries (A). Atypical cuboidal cells have proliferated along the slightly thickened alveolar wall. The epithelial cells of AAH have a round nucleus with a prominent nucleolus (B). H&E; original magnification, x30 (A) and x256 (B).

 


View larger version (139K):
[in this window]
[in a new window]
  		Figure 2. Representative histopathological findings of bronchiolar metaplasia. Ciliated columnar cells have extended from the bronchus to the alveoli without atypia. H&E; original magnification, x38 (A) and x206 (B).

 
Strategy for Clonal Analysis

We conducted clonal analysis according to the method of Allen et al.23 The strategy is based on random X chromosome inactivation by methylation. This random inactivation occurs early in embryogenesis and remains conserved throughout cell division, even in tumors. The HUMARA on the X chromosome has a trinucleotide (CAG) repeat polymorphism. We used HpaII, which cannot digest methylated DNA, to cut DNA before polymerase chain reaction (PCR), so that only the methylated allele was amplified. If the methylation pattern is uniform because of monoclonality, there is only one PCR product after HpaII digestion, whereas if the methylation patterns differ (polyclonal), two PCR products are obtained for the trinucleotide repeat polymorphism. The HUMARA polymorphism results were compared with the normal sample used in the study. In monoclonal cases, if the longer or shorter allele is amplified after HpaII digestion, we refer to it as the l or s pattern of monoclonality, respectively.

DNA Extraction

The resected lungs were fixed with 100% methanol and embedded in paraffin. The paraffin blocks containing the BAC, AAH, or bronchiolar metaplasia that was found in routine pathological studies were cut into 5-µm sections and stained with hematoxylin and eosin (H&E). Approximately 500 cells were microdissected under a microscope (BX50W1, Olympus, Tokyo, Japan) by using a microcapillary tube drawn to a thin tip with a micropipette puller (PC-10, Narishige, Tokyo, Japan) and a joystick-operated hydraulic micromanipulator (ONO-125, Olympus-Narishige, Tokyo, Japan) (Figure 3) . The microdissected cells were allowed to adhere to Parafilm (American Can, Greenwich, CT) and placed into 500-µl microcentrifuge tubes. Adjacent normal lung tissue was scraped with a 27-gauge needle to provide a normal control. DNA was extracted with the DNA extractor WB kit (Wako Pure Chemicals, Osaka, Japan).



View larger version (148K):
[in this window]
[in a new window]
  		Figure 3. Precise microdissection. AAH cells (A) were microdissected out to prepare DNA extraction (B). H&E; original magnification, x300.

 
Polymerase Chain Reaction

DNA was digested with RsaI and with or without HpaII, and the HUMARA was then amplified by PCR as previously described.34 Amplification of the HUMARA in exon 1 was performed using primers AR1 and AR2, essentially as described by Mutter et al35 with slight modifications. Six percent (w/v) of dimethylsulfoxide and dGTP instead of 7-deaza-2'-dGTP were added. AR2 was labeled at the 3' end with fluorescein. The HUMARA PCR products were analyzed with an automatic sequencer (ALFred, Pharmacia, Uppsala, Sweden) and quantified with the Fragment Manager software package (Pharmacia).


   Results
Top
 Abstract
 Introduction
 Materials and Methods
 Results
Discussion
 References
 
The characteristics of the cases are summarized in Table 1 . Patient 1 had 28 AAHs, patient 2 had three, patient 7 had two, patient 3 had one, and patient 4 had one in the periphery of BAC. Patient 5 had three AAHs, one of which was located at the borders of the BAC. Patients 4 and 7 also had foci of bronchiolar metaplasia apart from the BAC. Patient 5 had three BACs in the right upper and middle lobes (in the S3ai, S3aii, and S4a).


View this table:
[in this window]
[in a new window]
  		Table 1. Clinical Features and Clonal Results

 
Five of the seven cases were informative, with two PCR products of HUMARA (s and l) in the normal control. All 10 AAHs analyzed and seven BACs showed a monoclonal pattern, whereas two foci of bronchial metaplasia and normal lung showed a polyclonal pattern (Table 1) . In cases 2 and 5, different foci of AAHs from individual patients showed both possible patterns of monoclonality, which meant some retained the shorter allele (s pattern of monoclonality) and others the longer allele (l pattern of monoclonality) (Figure 4A) .



View larger version (23K):
[in this window]
[in a new window]
  		Figure 4. Clonal analysis by amplification of the human androgen receptor gene with or without HpaII digestion in case 2 (A) and case 4 (B). BAC 2 and AAH 2-1 and 2 showed the l pattern of monoclonality, whereas AAH 2-3 showed the s pattern (A). AAH 4 located at the periphery of BAC 4 showed the s pattern of monoclonality, identical to that of BAC 4 (B). In contrast, bronchiolar metaplasia and normal lung showed a polyclonal pattern. BAC, bronchioloalveolar carcinoma; AAH, atypical adenomatous hyperplasia; NL, normal lung; BM, bronchiolar metaplasia.

 
Furthermore, in case 5, two BACs in the upper lobe showed the s pattern of monoclonality, whereas a BAC in the middle lobe showed the l pattern of monoclonality. Monoclonality was also seen in the AAH located at the periphery of BAC, and its pattern was identical to that of BAC in cases 4 and 5 (Figure 4B) .


   Discussion
Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
References
 
Several molecular analyses of AAH have been reported, including analyses for K-ras mutation17,18 and telomerase activity.20 Although it has not yet been determined whether AAH is a precursor lesion of BAC, evidence has been accumulating in support of the hypothesis that AAH is a preneoplastic lesion of BAC. In the present study, we clearly demonstrated monoclonal expansion of AAH on the basis of random X-chromosome inactivation.

Monoclonality of various tumors has been reported, including myeloproliferative disorders,24 leiomyoma, Wilms' tumor,25 Hodgkin's disease,26 gynecological cancer,27 and multiple cancer of bladder28 and breast.36 However, Murry et al37 have recently showed monoclonality of smooth muscle cells in human atherosclerosis, which is considered a non-neoplastic lesion. Nomura et al34 showed monoclonality of each pyloric gland in the stomach. These findings suggested three possible explanations for the monoclonality of AAH: 1) the size of patches (groups of cells with the same patterns of X-chromosome inactivation) in the alveolar epithelium was larger than the lesions investigated; 2) a single cell in a heterogeneous lesion responded to a growth stimulation and proliferated overwhelmingly; or 3) a single cell underwent transformation into a neoplasm. The patch size of normal alveolar cells has remained undetermined. The normal control in our study was polyclonal, because it contained not only alveolar cells but several capillary cells or interstitial cells. However, dissected metaplastic epithelium (bronchiolar metaplasia), which has been considered to be a reactive hyperplastic lesion, was found to be polyclonal in our study. The size of the area in which the cells were microdissected was similar for both bronchiolar metaplasia and AAH. Therefore, it is reasonable to conclude that the size of AAH was greater than the patch size. Clonal expansion of the cells carrying alterations of oncogenes and/or tumor suppressor genes defines neoplasia at a fundamental genetic level.17 Taken together, our present findings and previous reports of K-ras mutation in AAH17,18 led us to conclude that AAH is neoplastic and not reactive or hyperplastic.

Multiple AAHs have been found occasionally.19 AAH has never been thought to disseminate because AAH cells do not invade the pulmonary mesenchyme histopathologically. In our study, AAH 2-3 showed an l pattern of monoclonality, whereas AAH 2-1 and 2-2 showed an s pattern. These findings indicate that multiple AAHs are of multicentric origin and that each grows independently.

AAH is frequently seen at the borders of BAC as in cases 4 and 5, whose AAH and BAC showed the identical pattern of monoclonality. If BAC originates from AAH, their monoclonality should be identical. The possibility of the BAC and AAH at its borders in these two cases occurring by chance is 25%, even if independent lesions; therefore, clonal analysis of many cases is necessary to establish the relationship between AAH and BAC.5-12

Case 5 had three BACs in the right upper and middle lobes, and these BACs showed both possible patterns of monoclonality. This finding indicated that the middle lobe tumor was not a metastasis from the upper lobe tumors, but a multicentric primary tumor. Clonal analysis based on X-chromosome inactivation is one of the most useful methods of differentiating between multiple and metastatic cancers when the histological type of multiple tumors is similar, especially in gynecological or breast cancer.36,38 The ability to diagnose multiple primary or metastatic lung cancer by this method is limited, because 1) male cases cannot be analyzed; 2) 10% to 20% of female cases are not informative for homozygosity in the HUMARA polymorphic site; and 3) there is a 50% probability of identical X-chromosome inactivation occurring in two tumors even if their clonality is different. Noguchi et al39 showed that the p53 gene mutation pattern is an effective marker for diagnosis of tumor multiplicity. Therefore, a combination of clonal analysis and p53 mutation analysis would have a greater impact on the diagnosis of multiple cancer than either one of the two methods alone.

Genetic analysis of AAH used to be difficult, because AAHs are such small lesions and most of them are found incidentally during routine pathological examinations. In addition, whole-lung fixation with formalin makes it difficult to extract DNA and perform PCR on such small lesions as AAH. Fixation with methanol, however, can circumvent this problem because it is an excellent method for both DNA and morphological analyses.40 Furthermore, our precise microdissection method makes it possible to genetically analyze small lesions such as AAH.

In conclusion, AAH exhibited a monoclonal expansion of epithelial cells, whereas reactive lesions such as bronchiolar metaplasia showed polyclonality. Considering the fact that K-ras activation was reported previously in AAH, our findings strongly support the idea that AAH is a preneoplastic lesion rather than reactive hyperplasia. Our findings also supported the possibility of an adenoma-carcinoma sequence in lung carcinogenesis, based on the discovery of identical monoclonal patterns in BAC and AAH peripheral to it. Additional molecular analyses are necessary to further characterize the biological nature of AAH.


   Acknowledgements
 
We thank Professor Michio Yamakido, The Second Department of Internal Medicine, Hiroshima University School of Medicine, Hiroshima, Japan, for his encouragement during this study.


   Footnotes
 
Address reprint requests to Dr. Seiji Niho, the Division of Thoracic Oncology, National Cancer Center Hospital East, 6-5-1, Kashiwanoha, Kashiwa, Chiba 277-8577, Japan. E-mail: siniho{at}east.ncc.go.jp

Supported in part by a grant from the Ministry of Health and Welfare for the Second-term Comprehensive Strategy for Cancer Control and a grant-in aid for cancer research from the Ministry of Health and Welfare, Japan.

K. Mukai's current address: First Department of Pathology, Tokyo Medical University, Tokyo, Japan.

Accepted for publication September 17, 1998.


   References
Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Auerbach O, Saccomanno G, Kuschner M, Brown RD, Garfinkel L: Histological findings in the tracheobronchial tree of uranium miners and non-miners with lung cancer. Cancer 1978, 42:483-489[Medline]
  2. Carter D: Pathology of early squamous cell carcinoma of the lung. Pathol Annu 1978, 13:131-147
  3. Saccomanno G, Archer VE, Auerbach O, Saunders RP, Brennan LM: Development of carcinoma of the lung as reflected in exfoliated cells. Cancer 1974, 33:256-270[Medline]
  4. Clayton F: The spectrum and significance of bronchioloalveolar carcinomas. Pathol Annu 1988, 23:361-394
  5. Carey FA, Wallace WA, Fergusson RJ, Kerr KM, Lamb D: Alveolar atypical hyperplasia in association with primary pulmonary adenocarcinoma: a clinicopathological study of 10 cases. Thorax 1992, 47:1041-1043[Abstract]
  6. Colby TV, Koss MN, Travis WD. Bronchioloalveolar carcinoma. Atlas of Tumor Pathology: Tumors of the Lower Respiratory Tract, 3rd series, Fasc. 13. Washington DC, Armed Forces Institute of Pathology, 1995, pp 203–234
  7. Kerr KM, Carey FA, King G, Lamb D: Atypical alveolar hyperplasia: relationship with pulmonary adenocarcinoma, p53, and c-erbB-2 expression. J Pathol 1994, 174:249-256[Medline]
  8. Miller RR: Bronchioloalveolar cell adenomas. Am J Surg Pathol 1990, 14:904-912[Medline]
  9. Mori M, Chiba R, Takahashi T: Atypical adenomatous hyperplasia of the lung and its differentiation from adenocarcinoma: characterization of atypical cells by morphometry and multivariate cluster analysis. Cancer 1993, 72:2331-2340[Medline]
  10. Mori M, Tezuka F, Chiba R, Funae Y, Watanabe M, Nukiwa T, Takahashi T: Atypical adenomatous hyperplasia and adenocarcinoma of the human lung: their heterology in form and analogy in immunohistochemical characteristics. Cancer 1996, 77:665-674[Medline]
  11. Rao SK, Fraire AE: Alveolar cell hyperplasia in association with adenocarcinoma of lung. Mod Pathol 1995, 8:165-169[Medline]
  12. Shimosato Y, Noguchi M, Matsuno Y: Adenocarcinoma of the lung: its development and malignant progression. Lung Cancer 1993, 9:99-108
  13. Suzuki K, Nagai K, Yoshida J, Yokose T, Kodama T, Takahashi K, Nishimura M, Kawasaki H, Yokozaki M, Nishiwaki Y: The prognosis of resected lung carcinoma associated with atypical adenomatous hyperplasia: a comparison of the prognosis of well-differentiated adenocarcinoma associated with atypical adenomatous hyperplasia and intrapulmonary metastasis. Cancer 1997, 79:1521-1526[Medline]
  14. Suzuki K, Takahashi K, Yoshida J, Nishimura M, Yokose T, Nishiwaki Y, Nagai K: Synchronous double primary lung carcinomas associated with multiple atypical adenomatous hyperplasia. Lung Cancer 1998, 19:131-139[Medline]
  15. Nakayama H, Noguchi M, Tsuchiya R, Kodama T, Shimosato Y: Clonal growth of atypical adenomatous hyperplasia of the lung: cytofluorometric analysis of nuclear DNA content. Mod Pathol 1990, 3:314-320[Medline]
  16. Yokozaki M, Kodama T, Yokose T, Matsumoto T, Mukai K: Differentiation of atypical adenomatous hyperplasia and adenocarcinoma of the lung by use of DNA ploidy and morphometric analysis. Mod Pathol 1996, 9:1156-1164[Medline]
  17. Westra WH, Baas IO, Hruban RH, Askin FB, Wilson K, Offerhaus GJ, Slebos RJ: K-ras oncogene activation in atypical alveolar hyperplasias of the human lung. Cancer Res 1996, 56:2224-2228[Abstract/Free Full Text]
  18. Cooper CA, Carby FA, Bubb VJ, Lamb D, Kerr KM, Wyllie AH: The pattern of K-ras mutation in pulmonary adenocarcinoma defines a new pathway of tumour development in the human lung. J Pathol 1997, 181:401-404[Medline]
  19. Kitamura H, Kameda Y, Nakamura N, Nakatani Y, Inayama Y, Iida M, Noda K, Ogawa N, Shibagaki T, Kanisawa M: Proliferative potential and p53 overexpression in precursor and early stage lesions of bronchioloalveolar lung carcinoma. Am J Pathol 1995, 146:876-887[Abstract]
  20. Yashima K, Litzky LA, Kaiser L, Rogers T, Lam S, Wistuba II, Milchgrub S, Srivastava S, Piatyszek MA, Shay JW, Gazdar AF: Telomerase expression in respiratory epithelium during the multistage pathogenesis of lung carcinomas. Cancer Res 1997, 57:2373-2377[Abstract/Free Full Text]
  21. Fialkow PJ: Clonal origin of human tumors. Biochim Biophys Acta 1976, 458:283-321[Medline]
  22. Nowell PC: The clonal evolution of tumor cell populations. Science 1976, 194:23-28[Abstract/Free Full Text]
  23. Allen RC, Zoghbi HY, Moseley AB, Rosenblatt HM, Belmont JW: Methylation of HpaII and HhaI sites near the polymorphic CAG repeat in the human androgen-receptor gene correlates with X chromosome inactivation. Am J Hum Genet 1992, 51:1229-1239[Medline]
  24. Gilliland DG, Blanchard KL, Levy J, Perrin S, Bunn HF: Clonality in myeloproliferative disorders: analysis by means of the polymerase chain reaction. Proc Natl Acad Sci USA 1991, 88:6848-6852[Abstract/Free Full Text]
  25. Vogelstein B, Fearon ER, Hamilton SR, Feinberg AP: Use of restriction fragment length polymorphisms to determine the clonal origin of human tumors. Science 1985, 227:642-645[Abstract/Free Full Text]
  26. Pan LX, Diss TC, Peng HZ, Norton AJ, Isaacson PG: Nodular lymphocyte predominance Hodgkin's disease: a monoclonal or polyclonal B-cell disorder? Blood 1996, 87:2428-2434[Abstract/Free Full Text]
  27. Sawada M, Azuma C, Hashimoto K, Noguchi S, Ozaki M, Saji F, Tanizawa O: Clonal analysis of human gynecologic cancers by means of the polymerase chain reaction. Int J Cancer 1994, 58:492-496[Medline]
  28. Sidransky D, Frost P, Von Eschenbach A, Oyasu R, Preisinger AC, Vogelstein B: Clonal origin of bladder cancer. N Engl J Med 1992, 326:737-740[Abstract]
  29. Noguchi S, Motomura K, Inaji H, Imaoka S, Koyama H: Clonal analysis of human breast cancer by means of the polymerase chain reaction. Cancer Res 1992, 52:6594-6597[Abstract/Free Full Text]
  30. Barsky SH, Grossman DA, Ho J, Holmes EC: The multifocality of bronchioloalveolar lung carcinoma: evidence and implications of a multiclonal origin. Mod Pathol 1994, 7:633-640[Medline]
  31. Nettesheim P, Szakal AK: Morphogenesis of alveolar bronchiolization. Lab Invest 1972, 26:210-219[Medline]
  32. Colby TV, Koss MN, Travis WD. Morphologic diagnosis and heterogeneity of carcinoma of the lung. Atlas of Tumor Pathology: Tumors of the Lower Respiratory Tract, 3rd series, Fasc. 13. Washington DC, Armed Forces Institute of Pathology, 1995, pp 135–143
  33. Kodama T, Biyajima S, Watanabe S, Shimosato Y: Morphometric study of adenocarcinomas and hyperplastic epithelial lesions in the peripheral lung. Am J Clin Pathol 1986, 85:146-151[Medline]
  34. Nomura S, Kaminishi M, Sugiyama K, Oohara T, Esumi H: Clonal analysis of isolated single fundic and pyloric gland of stomach using X-linked polymorphism. Biochem Biophys Res Commun 1996, 226:385-390[Medline]
  35. Mutter GL, Boynton KA: PCR bias in amplification of androgen receptor alleles, a trinucleotide repeat marker used in clonality studies. Nucleic Acids Res 1995, 23:1411-1418[Abstract/Free Full Text]
  36. Noguchi S, Aihara T, Koyama H, Motomura K, Inaji H, Imaoka S: Discrimination between multicentric and multifocal carcinomas of the breast through clonal analysis. Cancer 1994, 74:872-877[Medline]
  37. Murry CE, Gipaya CT, Bartosek T, Benditt EP, Schwartz SM: Monoclonality of smooth muscle cells in human atherosclerosis. Am J Pathol 1997, 151:697-705[Abstract]
  38. Noguchi S, Motomura K, Inaji H, Imaoka S, Koyama H: Differentiation of primary and secondary breast cancer with clonal analysis. Surgery 1994, 115:458-462[Medline]
  39. Noguchi M, Maezawa N, Nakanishi Y, Matsuno Y, Shimosato Y, Hirohashi S: Application of the p53 gene mutation pattern for differential diagnosis of primary versus metastatic lung carcinomas. Diagn Mol Pathol 1993, 2:29-35[Medline]
  40. Noguchi M, Furuya S, Takeuchi T, Hirohashi S: Modified formalin and methanol fixation methods for molecular biological and morphological analyses. Pathol Int 1997, 47:685-691[Medline]



This article has been cited by other articles:


Home page
 CarcinogenesisHome page
T. Kohno, H. Kunitoh, K. Suzuki, S. Yamamoto, A. Kuchiba, Y. Matsuno, N. Yanagitani, and J. Yokota
Association of KRAS polymorphisms with risk for lung adenocarcinoma accompanied by atypical adenomatous hyperplasias
Carcinogenesis, May 1, 2008; 29(5): 957 - 963.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
N. Seki, T. Takasu, K. Mandai, M. Nakata, H. Saeki, Y. Heike, I. Takata, Y. Segawa, T. Hanafusa, and K. Eguchi
Expression of Eukaryotic Initiation Factor 4E in Atypical Adenomatous Hyperplasia and Adenocarcinoma of the Human Peripheral Lung
Clin. Cancer Res., October 1, 2002; 8(10): 3046 - 3053.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
J. P. van Dijk, L. H. Heuver, B. A. van der Reijden, R. A. Raymakers, T. de Witte, and J. H. Jansen
A Novel, Essential Control for Clonality Analysis with Human Androgen Receptor Gene Polymerase Chain Reaction
Am. J. Pathol., September 1, 2002; 161(3): 807 - 812.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Roentgenol.Home page
C. I. Henschke, D. F. Yankelevitz, R. Mirtcheva, G. McGuinness, D. McCauley, and O. S. Miettinen
CT Screening for Lung Cancer: Frequency and Significance of Part-Solid and Nonsolid Nodules
Am. J. Roentgenol., May 1, 2002; 178(5): 1053 - 1057.
[Abstract] [Full Text] [PDF]

Home page
 Jpn J Clin OncolHome page
H. Nomori, H. Horio, T. Naruke, K. Suemasu, S. Morinaga, and M. Noguchi
A Case of Multiple Atypical Adenomatous Hyperplasia of the Lung Detected by Computed Tomography
Jpn. J. Clin. Oncol., October 1, 2001; 31(10): 514 - 516.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Pathol.Home page
K M Kerr
Pulmonary preinvasive neoplasia
J. Clin. Pathol., April 1, 2001; 54(4): 257 - 271.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
R Nakahara, T Yokose, K Nagai, Y Nishiwaki, and A Ochiai
Atypical adenomatous hyperplasia of the lung: a clinicopathological study of 118 cases including cases with multiple atypical adenomatous hyperplasia
Thorax, April 1, 2001; 56(4): 302 - 305.
[Abstract] [Full Text]

Home page
 Ann. Thorac. Surg.Home page
K. Suzuki, T. Yokose, J. Yoshida, M. Nishimura, K. Takahashi, K. Nagai, and Y. Nishiwaki
Prognostic significance of the size of central fibrosis in peripheral adenocarcinoma of the lung
Ann. Thorac. Surg., March 1, 2000; 69(3): 893 - 897.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Niho, S.
Right arrow Articles by Mukai, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Niho, S.
Right arrow Articles by Mukai, K.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS